Search for Clinical Trial Results

Sponsored By

Hidradenitis Suppurativa - 27 Studies Found

Status Study
Completed Study Name: Etanercept in Hidradenitis Suppurativa
Condition: Hidradenitis Suppurativa
Date: 2006-05-23
Interventions: Drug: Etanercept sc 50mg per week for 12 weeks
Completed Study Name: Study to Compare Two Treatments for Axillary Hidradenitis Suppurativa: Carbon Dioxide Laser Versus Surgical Deroofing
Condition: Hidradenitis Suppurativa
Date: 2014-06-12
Interventions:
  • Procedure: CO2 (carbon dioxide) laser
  • Proc
Completed Study Name: Study on the Effect of NdYag Laser for the Treatment of Hidradenitis Suppurativa
Condition: Hidradenitis Suppurativa
Date: 2007-06-27
Interventions: Procedure: Long-pulsed Nd:YAG laser 1064 nm Laser once monthly
Completed Study Name: Anakinra as a Treatment for Hydradenitis Suppurativa
Condition: Hidradenitis Suppurativa
Date: 2011-12-07
Interventions: Drug: anakinra Anakinra is supplied in individual pre-filled glass syringes 100mg/0.67mL each. It will b
Recruiting Study Name: Treatment of Hidradenitis Suppurativa With Eth 755nm Alexandrite Laser
Condition: Hidradenitis Suppurativa
Date: 2017-02-09
Interventions: Device: Alexandrite Laser Alexandrite 755nm hair removal laser
Recruiting Study Name: Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients - a Multi cOuNtry studY in Real Life Setting
Condition: Hidradenitis Suppurativa
Date: 2016-05-26
Recruiting Study Name: Trial Comparing Efficacy of Treatments for Hidradenitis Suppurativa
Condition: Hidradenitis Suppurativa
Date: 2010-02-02
Interventions:
  • Drug: Clindamycin & Rifampin

Recruiting Study Name: Post-Marketing Surveillance of Adalimumab in Korean Hidradenitis Suppurativa Subjects
Condition: Hidradenitis Suppurativa
Date: 2016-12-20
Completed Study Name: Efficacy and Safety of Efalizumab in the Treatment of Moderate-Severe Hydradenitis Suppurativa
Condition: Hidradenitis Suppurativa
Date: 2005-08-23
Interventions: Drug: efalizumab
Completed Study Name: Efficacy, Safety, and Pharmacokinetics Study of CJM112 in Hidradenitis Suppurativa Patients
Condition: Hidradenitis Suppurativa (Acne Inversa)
Date: 2015-03-18
Interventions: Biological: CJM112 Fully human IgG1 monoclonal antibody
Next >>>